Predictive Oncology (POAI) Stock Statistics & Valuation Metrics

Predictive Oncology has a market cap or net worth of $9.85M. The enterprise value is $9.17M.

Predictive Oncology has 10,892,657 shares outstanding. The number of shares has decreased by -2.65% in one year.

Predictive Oncology’s return on equity (ROE) is 60.22 and return on invested capital (ROIC) is -560.47%.

The current PE Ratio of Predictive Oncology is ―. Predictive Oncology’s PEG ratio is ―.

In the last 12 months, Predictive Oncology had revenue of 1.62M and earned -12.20M in profits. Earnings per share was -2.24.

In the last 12 months, operating cash flow was -8.62M and capital expenditures -3.00, giving a free cash flow of -8.62M billion.

Predictive Oncology pays an annual dividend of ―, resulting in a dividend yield of ―

Predictive Oncology upcoming earnings date is Nov 6, 2025, After Close (Confirmed).

Predictive Oncology as a current ratio of 0.62, with Debt / Equity ratio of -111.66%

In the past 12 months, Predictive Oncology has paid 0.00 in taxes.

Predictive Oncology EV to EBITDA ratio is -0.57, with an EV/FCF ratio of -0.53.

Predictive Oncology has $506.08K in cash and marketable securities with $1.85M in debt, giving a net cash position of $1.34M billion.

Gross margin is 32.62%, with operating margin of -673.69%, and net profit margin of -751.39%.

The average price target for Predictive Oncology is $1.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell